Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 101 clinical trials
Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF) (GAP)

The purpose of the study is to identify genetic and biologic markers that may predict the loss of lung function due to idiopathic pulmonary fibrosis. The studies will compare genetic and

idiopathic pulmonary fibrosis
pulmonary function test
  • 39 views
  • 23 Jan, 2022
  • 1 location
Dyspnea and Idiopathic Pulmonary Fibrosis (DYS-PID)

Longitudinal prospective exploratory study on the evolution of dyspnea, in its sensory and affective dimensions, in patients followed for idiopathic pulmonary fibrosis (IPF), between inclusion

idiopathic pulmonary fibrosis
dyspnea
pulmonary fibrosis
fibrosis
  • 0 views
  • 19 Apr, 2022
  • 1 location
Cohort of IPF Patients Experiencing an Exacerbation

Extension of the PFBIO cohort which includes patients with newly diagnosed idiopathic pulmonary fibrosis (IPF) for longitudinal follow-up for up to 5 years. In the PFBIO-EXA extension

  • 0 views
  • 10 Nov, 2021
  • 1 location
The Role of Laryngopharyngeal Reflux in IPF

(LPF) in idiopathic pulmonary fibrosis (IPF).

idiopathic pulmonary fibrosis
laryngopharyngeal reflux
gastroesophageal reflux
  • 33 views
  • 13 Oct, 2022
  • 1 location
Validation of the Risk Stratification Score in Idiopathic Pulmonary Fibrosis

Idiopathic pulmonary fibrosis (IPF) is characterized by a poor prognosis, with a progressive decline in lung function and a considerable variability in the disease's natural history. Besides

idiopathic pulmonary fibrosis
scarring
diffusion capacity of the lung for carbon monoxide
hypertension
dyspnea
  • 138 views
  • 25 Nov, 2021
  • 2 locations
Pulmonary Fibrosis Biomarker Cohort - a Prospective Cohort of Incident Patients With IPF (PFBIO)

Incident patients with idiopathic pulmonary fibrosis (IPF) in Denmark will be offered inclusion and followed up for up to 5 years with measurements of blood biomarkers and measurements of

idiopathic pulmonary fibrosis
  • 81 views
  • 24 Feb, 2022
  • 1 location
Early Diagnosis of Pulmonary Fibrosis - Diagnostic Delay

Patients with newly diagnosed IPF are investigated for the diagnostic delay before a diagnosis of IPF is made.

  • 67 views
  • 23 Feb, 2022
  • 2 locations
Integrated Radiographic and Metabolomics Risk Assessment in Patients With Interstitial Lung Diseases (IRM-ILD)

most common ILD is idiopathic pulmonary fibrosis (IPF). Metabolomics provides a "snapshot" in time of all metabolites present in a biological sample. The imaging procedure should take approximately 20

idiopathic pulmonary fibrosis
interstitial lung disease
chronic obstructive pulmonary disease
pulmonary function test
pulmonary disease
  • 44 views
  • 06 May, 2022
  • 1 location
Sleep Hygiene, Sarcopenia, and Cognitive Function in Respiratory Disease

We aim to clarify the relationship between sleep hygiene and the onset of sarcopenia or cognitive dysfunction using sleep time, arousal, and sleep quality as indicators in COPD or IPF patients

  • 0 views
  • 24 Mar, 2022
  • 1 location